Outcomes of gynecologic oncology patients undergoing gastrografin small bowel follow-through studies.

Academic Article

Abstract

  • OBJECTIVE: To characterize the outcomes of gynecologic oncology patients undergoing small bowel follow-throughs (SBFTs) with Gastrografin at our institution. STUDY DESIGN: We identified all gynecologic oncology patients undergoing an SBFT from January 2004 to December 2009. We characterized the SBFT as normal, delayed transit, partial obstruction, or complete obstruction. Patient outcomes were correlated with the SBFT results. RESULTS: Seventy patients underwent 79 SBFT examinations with Gastrografin to evaluate their bowel dysfunction. The overall rate of operative intervention was 23%. A total of 69% of patients with a complete obstruction underwent surgery as compared to 21% of patients with a partial obstruction (p = 0.002). Return of bowel function was significantly longer in patients with complete obstructions as compared to patients with partial obstructions (48 vs. 8 hours, p = 0.006). Length of stay was longest in patients with complete obstructions. CONCLUSION: The majority of patients with a complete obstruction on SBFT will require surgical intervention and have a protracted hospital stay. Patients with delayed transit or a partial obstruction on SBFT usually will have resolution of their bowel dysfunction with conservative management.
  • Published In

    Keywords

  • Adult, Aged, Aged, 80 and over, Diatrizoate Meglumine, Female, Genital Neoplasms, Female, Humans, Intestinal Obstruction, Intestine, Small, Middle Aged, Radiography, Recovery of Function, Retrospective Studies, Treatment Outcome, Young Adult
  • Author List

  • Walters CL; Sutton ALM; Huddleston-Colburn MK; Whitworth JM; Schneider KE; Straughn JM
  • Start Page

  • 476
  • End Page

  • 480
  • Volume

  • 59
  • Issue

  • 9-10